Glutathione Transferase Gene Variants Influence Busulfan Pharmacokinetics and Outcome After Myeloablative Conditioning for Stem Cell Transplantation.

被引：0
|
作者：
Bremer, S. [1 ]
Floeisand, Y. [2 ]
Bergan, S. [3 ,4 ]
机构：
[1] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway
[2] Oslo Univ Hosp, Dept Hematol, Oslo, Norway
[3] Oslo Univ Hosp, Dept Pharmacol, Oslo, Norway
[4] Univ Oslo, Sch Pharm, Oslo, Norway
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
10.1097/00007890-201407151-03003
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
A30
引用
收藏
页码：880 / 880
页数：1
相关论文
共 50 条
  • [1] Glutathione Transferase Gene Variants Influence Busulfan Pharmacokinetics and Outcome After Myeloablative Conditioning for Stem Cell Transplantation.
    Bremer, S.
    Floeisand, Y.
    Bergan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 880 - 880
  • [2] Glutathione Transferase Gene Variants Influence Busulfan Pharmacokinetics and Outcome After Myeloablative Conditioning
    Bremer, Sara
    Floisand, Yngvar
    Brinch, Lorentz
    Gedde-Dahl, Tobias
    Bergan, Stein
    THERAPEUTIC DRUG MONITORING, 2015, 37 (04) : 493 - 500
  • [3] Glutathione S transferase gene variations influence busulfan pharmacokinetics and outcome of haematopoietic stem cell transplantation
    Krajinovic, M.
    Rezgui, M. A.
    Theoret, Y.
    Duval, M.
    Meziani, S.
    Rousseau, J.
    Labuda, M.
    Pryzbila, C.
    Vachon, M.
    Desjean, C.
    Champagne, M.
    Peters, C.
    Bittencourt, H.
    Ansari, M.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S41 - S41
  • [4] Influence of glutathione S-transferase gene polymorphisms on busulfan pharmacokinetics and outcome of hematopoietic stem-cell transplantation in thalassemia pediatric patients
    M Ansari
    P Huezo-Diaz
    M A Rezgui
    S Marktel
    M Duval
    H Bittencourt
    B Cappelli
    M Krajinovic
    Bone Marrow Transplantation, 2016, 51 : 377 - 383
  • [5] Influence of glutathione S-transferase gene polymorphisms on busulfan pharmacokinetics and outcome of hematopoietic stem-cell transplantation in thalassemia pediatric patients
    Ansari, M.
    Huezo-Diaz, P.
    Rezgui, M. A.
    Marktel, S.
    Duval, M.
    Bittencourt, H.
    Cappelli, B.
    Krajinovic, M.
    BONE MARROW TRANSPLANTATION, 2016, 51 (03) : 377 - 383
  • [6] Influence of Fludarabine Pharmacokinetics on Outcome of Allogeneic Stem Cell Transplantation with Fludarabine-Busulfan Conditioning
    Manna, Mita
    Daly, Andrew
    Kangarloo, Bill
    Savoie, Mary Lynn
    Storek, Jan
    BLOOD, 2015, 126 (23)
  • [7] Outcome After Cord Blood Transplantation Using Busulfan Pharmacokinetics-Targeted Myeloablative Conditioning for Hurler Syndrome
    Lum, Su Han
    Orchard, Paul J.
    Lund, Troy C.
    Miller, Weston P.
    Boelens, Jaap Jan
    Wynn, Robert
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (01):
  • [8] Pharmacokinetics and tolerability of intravenous busulfan in hematopoietic stem cell transplantation.
    Yoon, Sung-Soo
    Cho, Yo-Han
    Lim, Hyun-Ae
    Kim, Inho
    Bang, Soo-Mee
    Lee, Jong Seok
    Park, Seonyang
    Kim, Byoung KooK
    BLOOD, 2006, 108 (11) : 404B - 404B
  • [9] Fludarabine - Oral busulfan myeloablative conditioning for allogenic peripheral stem cell transplantation. A single center experience in Colombia
    Rosales, C.
    Abello, V.
    Rosales, E.
    Esguerra, H.
    Linares, A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 97 - 97
  • [10] Impact of Glutathione S-Transferase Polymorphisms on Busulfan Pharmacokinetics and Outcomes of Hematopoietic Stem Cell Transplantation
    Al-Riyami, Intisar
    Al-Khabori, Murtadha
    Al Balushi, Khalid
    Al-Zadjali, Shoaib
    Al-Rawahi, Mohammed
    Dennison, David
    Al-Hunaini, Mohammed
    Al-Rawas, Abdulhakeem
    Al-Moundhri, Mansour
    THERAPEUTIC DRUG MONITORING, 2022, 44 (04) : 527 - 534
12345